205 related articles for article (PubMed ID: 17032757)
21. Structural basis for binding multiple ligands by the common cytokine receptor gamma-chain.
Olosz F; Malek TR
J Biol Chem; 2002 Apr; 277(14):12047-52. PubMed ID: 11815609
[TBL] [Abstract][Full Text] [Related]
22. Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha chain.
Waheed N; Naseer M; Haider N; Suleman S; Ullah A
Immunogenetics; 2023 Apr; 75(2):71-79. PubMed ID: 36195682
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity.
Rao BM; Girvin AT; Ciardelli T; Lauffenburger DA; Wittrup KD
Protein Eng; 2003 Dec; 16(12):1081-7. PubMed ID: 14983090
[TBL] [Abstract][Full Text] [Related]
24. Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions.
Raimundo BC; Oslob JD; Braisted AC; Hyde J; McDowell RS; Randal M; Waal ND; Wilkinson J; Yu CH; Arkin MR
J Med Chem; 2004 Jun; 47(12):3111-30. PubMed ID: 15163192
[TBL] [Abstract][Full Text] [Related]
25. The c.305del3 in IL-2 gene in Homonoidea theoretically affects IL-2/IL-2Rα interaction as well as lymphocyte homeostasis.
Hosseinian H; Mahnam K; Shakhsi-Niaei M
Cytokine; 2018 Aug; 108():232-238. PubMed ID: 29246655
[TBL] [Abstract][Full Text] [Related]
26. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.
Pillet AH; Lavergne V; Pasquier V; Gesbert F; Thèze J; Rose T
J Mol Biol; 2010 Nov; 403(5):671-92. PubMed ID: 20816854
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.
Ascherman DP; Migone TS; Friedmann MC; Leonard WJ
J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703
[TBL] [Abstract][Full Text] [Related]
28. [Screening of short peptides binding to cell surface interleukin-2 receptor alpha chain].
Liu BY; Zhu P; Luo HB; Fu N
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):971-4. PubMed ID: 16864089
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.
Spangler JB; Tomala J; Luca VC; Jude KM; Dong S; Ring AM; Votavova P; Pepper M; Kovar M; Garcia KC
Immunity; 2015 May; 42(5):815-25. PubMed ID: 25992858
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans.
Chirifu M; Hayashi C; Nakamura T; Toma S; Shuto T; Kai H; Yamagata Y; Davis SJ; Ikemizu S
Nat Immunol; 2007 Sep; 8(9):1001-7. PubMed ID: 17643103
[TBL] [Abstract][Full Text] [Related]
31. Docking of human interleukin-15 to its specific receptor alpha chain: correlation between molecular modeling and mutagenesis experimental data.
Quéméner A; Bernard J; Mortier E; Plet A; Jacques Y; Tran V
Proteins; 2006 Nov; 65(3):623-36. PubMed ID: 17001647
[TBL] [Abstract][Full Text] [Related]
32. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
Imbert V; Rezzonico R; Reichenbach P; Nabholz M
Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
[TBL] [Abstract][Full Text] [Related]
33. Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.
Malka Y; Hornakova T; Royer Y; Knoops L; Renauld JC; Constantinescu SN; Henis YI
J Biol Chem; 2008 Nov; 283(48):33569-77. PubMed ID: 18829468
[TBL] [Abstract][Full Text] [Related]
34. The protein-protein interface evolution acts in a similar way to antibody affinity maturation.
Li B; Zhao L; Wang C; Guo H; Wu L; Zhang X; Qian W; Wang H; Guo Y
J Biol Chem; 2010 Feb; 285(6):3865-3871. PubMed ID: 20007707
[TBL] [Abstract][Full Text] [Related]
35. T cell signaling and Treg dysfunction correlate to disease kinetics in IL-2Rα-KO autoimmune mice.
Mullins GN; Valentine KM; Al-Kuhlani M; Davini D; Jensen KDC; Hoyer KK
Sci Rep; 2020 Dec; 10(1):21994. PubMed ID: 33319815
[TBL] [Abstract][Full Text] [Related]
36. Diphtheria toxin-based bivalent human IL-2 fusion toxin with improved efficacy for targeting human CD25(+) cells.
Peraino JS; Zhang H; Rajasekera PV; Wei M; Madsen JC; Sachs DH; Huang CA; Wang Z
J Immunol Methods; 2014 Mar; 405():57-66. PubMed ID: 24462799
[TBL] [Abstract][Full Text] [Related]
37. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
[TBL] [Abstract][Full Text] [Related]
38. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab.
Du J; Yang H; Zhang D; Wang J; Guo H; Peng B; Guo Y; Ding J
J Immunol; 2010 Feb; 184(3):1361-8. PubMed ID: 20032294
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains.
Murphy JM; Ford SC; Olsen JE; Gustin SE; Jeffrey PD; Ollis DL; Young IG
J Biol Chem; 2004 Jun; 279(25):26500-8. PubMed ID: 15060062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
